# Jackson Financial Inc.: financial statements, quarterly

JXN · NYSE · CIK 1822993 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jxn.md) · [Financials](/companies/jxn/financials.md) · [Filings](/companies/jxn/filings.md) · [Insiders](/companies/jxn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jxn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,585](/filings/0001822993-24-000037.md) | [882 d](/filings/0001822993-26-000022.md) | [(322)](/filings/0001822993-25-000017.md) | [1,247](/filings/0001822993-25-000030.md) | [2,121](/filings/0001822993-25-000089.md) | [225 d](/filings/0001822993-26-000022.md) | [3,750](/filings/0001822993-26-000072.md) | [(471)](/filings/0001822993-26-000124.md) | [1,416](/filings/0001822993-25-000089.md) | [1,988 d](/filings/0001822993-26-000022.md) | [2,902](/filings/0001822993-26-000072.md) | [168](/filings/0001822993-26-000124.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [28.0](/filings/0001822993-24-000037.md) | [25.0 d](/filings/0001822993-26-000022.md) | [25.0](/filings/0001822993-25-000017.md) | [26.0](/filings/0001822993-25-000030.md) | [25.0](/filings/0001822993-25-000089.md) | [25.0 d](/filings/0001822993-26-000022.md) | [25.0](/filings/0001822993-26-000072.md) | [25.0](/filings/0001822993-26-000124.md) | [25.0](/filings/0001822993-25-000089.md) | [25.0 d](/filings/0001822993-26-000022.md) | [25.0](/filings/0001822993-26-000072.md) | [27.0](/filings/0001822993-26-000124.md) |
| Income tax | $m | [712](/filings/0001822993-24-000037.md) | [(395) d](/filings/0001822993-26-000022.md) | [101](/filings/0001822993-25-000017.md) | [36.0](/filings/0001822993-25-000030.md) | [(113)](/filings/0001822993-25-000089.md) | [22.0 d](/filings/0001822993-26-000022.md) | [1.0](/filings/0001822993-26-000072.md) | [4.0](/filings/0001822993-26-000124.md) | [(19.0)](/filings/0001822993-25-000089.md) | [(172) d](/filings/0001822993-26-000022.md) | [20.0](/filings/0001822993-26-000072.md) | [5.0](/filings/0001822993-26-000124.md) |
| Net income | $m | [2,773](/filings/0001822993-24-000037.md) | [(1,559) d](/filings/0001822993-26-000022.md) | [795](/filings/0001822993-25-000017.md) | [275](/filings/0001822993-25-000030.md) | [(469)](/filings/0001822993-25-000089.md) | [345 d](/filings/0001822993-26-000022.md) | [(24.0)](/filings/0001822993-26-000072.md) | [179](/filings/0001822993-26-000124.md) | [76.0](/filings/0001822993-25-000089.md) | [(204) d](/filings/0001822993-26-000022.md) | [(424)](/filings/0001822993-26-000072.md) | [655](/filings/0001822993-26-000124.md) |
| Diluted EPS | $ per share | [33.35](/filings/0001822993-24-000037.md) | not reported | [9.94](/filings/0001822993-25-000017.md) | [3.43](/filings/0001822993-25-000030.md) | [(6.37)](/filings/0001822993-25-000089.md) | not reported | [(0.48)](/filings/0001822993-26-000072.md) | [2.34](/filings/0001822993-26-000124.md) | [0.92](/filings/0001822993-25-000089.md) | not reported | [(6.24)](/filings/0001822993-26-000072.md) | [9.16](/filings/0001822993-26-000124.md) |
| Basic EPS | $ per share | [33.66](/filings/0001822993-24-000037.md) | not reported | [10.04](/filings/0001822993-25-000017.md) | [3.45](/filings/0001822993-25-000030.md) | [(6.37)](/filings/0001822993-25-000089.md) | not reported | [(0.48)](/filings/0001822993-26-000072.md) | [2.34](/filings/0001822993-26-000124.md) | [0.93](/filings/0001822993-25-000089.md) | not reported | [(6.24)](/filings/0001822993-26-000072.md) | [9.18](/filings/0001822993-26-000124.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.8](/filings/0001822993-24-000037.md) | [2.7](/filings/0001822993-26-000022.md) | [2.5](/filings/0001822993-25-000017.md) | [1.7](/filings/0001822993-25-000030.md) | [3.1](/filings/0001822993-25-000089.md) | [3.8](/filings/0001822993-26-000022.md) | [3.9](/filings/0001822993-26-000072.md) | [3.8](/filings/0001822993-26-000124.md) | [4.6](/filings/0001822993-25-000089.md) | [5.7](/filings/0001822993-26-000124.md) | [5.5](/filings/0001822993-26-000072.md) | [6.0](/filings/0001822993-26-000124.md) |
| Total assets | $bn | [315](/filings/0001822993-23-000047.md) | [330](/filings/0001822993-25-000011.md) | [340](/filings/0001822993-24-000020.md) | [338](/filings/0001822993-24-000028.md) | [346](/filings/0001822993-24-000037.md) | [338](/filings/0001822993-26-000022.md) | [327](/filings/0001822993-25-000017.md) | [344](/filings/0001822993-25-000030.md) | [354](/filings/0001822993-25-000089.md) | [353](/filings/0001822993-26-000124.md) | [340](/filings/0001822993-26-000072.md) | [367](/filings/0001822993-26-000124.md) |
| Total liabilities | $bn | [304](/filings/0001822993-23-000047.md) | [320](/filings/0001822993-25-000011.md) | [330](/filings/0001822993-24-000020.md) | [327](/filings/0001822993-24-000028.md) | [335](/filings/0001822993-24-000037.md) | [328](/filings/0001822993-26-000022.md) | [317](/filings/0001822993-25-000017.md) | [333](/filings/0001822993-25-000030.md) | [343](/filings/0001822993-25-000089.md) | [342](/filings/0001822993-26-000124.md) | [330](/filings/0001822993-26-000072.md) | [357](/filings/0001822993-26-000124.md) |
| Long-term debt | $bn | [2.6](/filings/0001822993-23-000047.md) | [2.0](/filings/0001822993-25-000011.md) | [2.0](/filings/0001822993-24-000020.md) | [2.0](/filings/0001822993-24-000028.md) | [2.0](/filings/0001822993-24-000037.md) | [2.0](/filings/0001822993-26-000022.md) | [2.0](/filings/0001822993-25-000017.md) | [2.0](/filings/0001822993-25-000030.md) | [2.0](/filings/0001822993-25-000089.md) | [2.0](/filings/0001822993-26-000124.md) | [2.0](/filings/0001822993-26-000072.md) | [2.8](/filings/0001822993-26-000124.md) |
| Short-term borrowings | $bn | [1.2](/filings/0001822993-23-000047.md) | [1.0](/filings/0001822993-24-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [9.5](/filings/0001822993-23-000047.md) | [10.2](/filings/0001822993-25-000011.md) | [10.2](/filings/0001822993-24-000020.md) | [10.1](/filings/0001822993-24-000028.md) | [10.7](/filings/0001822993-24-000037.md) | [9.8](/filings/0001822993-26-000022.md) | [10.3](/filings/0001822993-25-000017.md) | [10.4](/filings/0001822993-25-000030.md) | [10.2](/filings/0001822993-25-000089.md) | [10.0](/filings/0001822993-26-000124.md) | [9.5](/filings/0001822993-26-000072.md) | [10.0](/filings/0001822993-26-000124.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,129 d](/filings/0001822993-24-000037.md) | [1,634 d](/filings/0001822993-26-000022.md) | [1,426](/filings/0001822993-25-000017.md) | [1,478 d](/filings/0001822993-25-000030.md) | [1,364 d](/filings/0001822993-25-000089.md) | [1,525 d](/filings/0001822993-26-000022.md) | [1,594](/filings/0001822993-26-000072.md) | [1,173 d](/filings/0001822993-26-000124.md) | [1,370 d](/filings/0001822993-25-000089.md) | [1,621 d](/filings/0001822993-26-000022.md) | [1,045](/filings/0001822993-26-000072.md) | [1,849 d](/filings/0001822993-26-000124.md) |
| Dividends paid | $m | [51.0 d](/filings/0001822993-24-000037.md) | [49.0 d](/filings/0001822993-26-000022.md) | [54.0](/filings/0001822993-25-000017.md) | [53.0 d](/filings/0001822993-25-000030.md) | [53.0 d](/filings/0001822993-25-000089.md) | [51.0 d](/filings/0001822993-26-000022.md) | [58.0](/filings/0001822993-26-000072.md) | [57.0 d](/filings/0001822993-26-000124.md) | [54.0 d](/filings/0001822993-25-000089.md) | [54.0 d](/filings/0001822993-26-000022.md) | [64.0](/filings/0001822993-26-000072.md) | [62.0 d](/filings/0001822993-26-000124.md) |
| Share repurchases | $m | [72.0 d](/filings/0001822993-24-000037.md) | [70.0 d](/filings/0001822993-26-000022.md) | [120](/filings/0001822993-25-000017.md) | [109 d](/filings/0001822993-25-000030.md) | [114 d](/filings/0001822993-25-000089.md) | [99.0 d](/filings/0001822993-26-000022.md) | [202](/filings/0001822993-26-000072.md) | [158 d](/filings/0001822993-26-000124.md) | [157 d](/filings/0001822993-25-000089.md) | [152 d](/filings/0001822993-26-000022.md) | [227](/filings/0001822993-26-000072.md) | [227 d](/filings/0001822993-26-000124.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [87.9](/filings/0001822993-23-000047.md) | [82.6](/filings/0001822993-24-000020.md) | [84.8](/filings/0001822993-24-000028.md) | [82.8](/filings/0001822993-24-000037.md) | [78.9](/filings/0001822993-25-000017.md) | [77.1](/filings/0001822993-25-000030.md) | [75.4](/filings/0001822993-25-000089.md) | [73.5](/filings/0001822993-26-000072.md) | [71.9](/filings/0001822993-26-000124.md) | [70.3](/filings/0001822993-25-000089.md) | [69.7](/filings/0001822993-26-000072.md) | [70.3](/filings/0001822993-26-000124.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,728,744 at 2026-07-27, from the cover of the [10-Q filed 2026-08-03](/filings/0001822993-26-000124.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.